← All news
Markets
Did Beacon's Trial Win Just Lift Syncona (LSE:SYNC) Into A New Chapter This Week?
Highlights Beacon Therapeutics said its pivotal VISTA trial met its FDA-endorsed primary endpoint. Syncona shares surged on the readout, as Beacon ranks among its largest holdings. The investor has flagged several value inflection points ac…
Covered by 1 outlet
All coverage · 1 article